Form 4: SOPHiA GENETICS Officer Sells Shares

SOPHiA GENETICS SA Chief Medical Officer, Philippe Menu, reported a sale of 7,393 ordinary shares on July 6, 2026, executed under a Rule 10b5-1 trading plan.

Summary

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 7,393 ordinary shares on July 6, 2026.
• The sale was conducted under a pre-established Rule 10b5-1(c) trading plan.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock units on July 2 and July 3, 2026.
• The shares were sold at a weighted average price of $5.1611, with individual sales ranging from $4.97 to $5.44.
• Following the transaction, Philippe Menu beneficially owns 233,387 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it involves a sale of shares by an executive, it is clearly attributed to tax obligations and executed under a pre-defined, compliant trading plan (Rule 10b5-1), mitigating concerns of discretionary selling based on non-public information.

Negatives

• Sale of company shares by a key executive, although explained as a tax-related transaction under a pre-planned trading strategy.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, particularly those related to tax obligations or pre-arranged trading plans like Rule 10b5-1, are common. The key is to distinguish between discretionary sales and those executed under established plans, as this filing indicates the latter.

Stakeholder Impact

• Shareholders: The sale is a routine transaction for tax purposes under a pre-planned strategy, thus unlikely to have a significant negative impact on share price or investor confidence.
• Employees: The transaction is specific to the executive's equity awards and tax obligations, with no direct impact on other employees.
• Management: Demonstrates adherence to corporate governance by utilizing a Rule 10b5-1 plan for managing equity sales related to compensation.

Key Dates

Keywords

SOPHiA GENETICS SA, SOPH, Form 4, Insider Trading, Share Sale, Rule 10b5-1, Chief Medical Officer, Philippe Menu, Tax Withholding, Restricted Stock Units